{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"The combined rate of CR and VGPR was defined as the percentage of participants who achieved a best response of either CR or VGPR.","groups":[{"description":"This substudy was withdrawn; therefore, no participants were enrolled.","id":"OG000","title":"Substudy A (Relapsed/Refractory Waldenstrom Macroglobulinemia): Brexucabtagene Autoleucel"}],"populationDescription":"Substudy A was withdrawn, therefore no participants were enrolled in it. Hence, data is not available.","reportingStatus":"POSTED","timeFrame":"Up to 2 years","title":"Substudy A: Percentage of Participants With Combined CR and VGPR Determined by Investigator Assessment Per the Sixth International Workshop in WM","type":"SECONDARY"}